Gluck S - Search Results

1

Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16.

Crump M, Gluck S, Tu D, Stewart D, Levine M, Kirkbride P, Dancey J, O'Reilly S, Shore T, Couban S, Girouard C, Marlin S, Shepherd L, Pritchard KI. Crump M, et al. Among authors: gluck s. J Clin Oncol. 2008 Jan 1;26(1):37-43. doi: 10.1200/JCO.2007.11.8851. Epub 2007 Nov 19. J Clin Oncol. 2008. PMID: 18025439 Clinical Trial.

2

Current status of high dose chemotherapy in breast cancer.

Glück S, Stewart D. Glück S, et al. Przegl Lek. 2000;57 Suppl 1:30-2. Przegl Lek. 2000. PMID: 10822993 Review.

3

What's happening? Current status of high dose chemotherapy in breast cancer.

Glück S, Stewart D. Glück S, et al. Transfus Sci. 1999 Dec;21(3):211-4. doi: 10.1016/s0955-3886(99)00095-8. Transfus Sci. 1999. PMID: 10848443 Review.

4

Phase II study of sequential topotecan and etoposide in patients with intermediate grade non-Hodgkin's lymphoma: a National Cancer Institute of Canada Clinical Trials Group study.

Crump M, Couban S, Meyer R, Rudinskas L, Zanke B, Gluck S, Maksymiuk A, Hoskins P, Matthews S, Eisenhauer E. Crump M, et al. Among authors: gluck s. Leuk Lymphoma. 2002 Aug;43(8):1581-7. doi: 10.1080/1042819021000002901. Leuk Lymphoma. 2002. PMID: 12400600 Clinical Trial.

5

Expression of C-erbB-2/HER-2 in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous blood stem cell support.

Bewick M, Chadderton T, Conlon M, Lafrenie R, Morris D, Stewart D, Glück S. Bewick M, et al. Among authors: gluck s. Bone Marrow Transplant. 1999 Aug;24(4):377-84. doi: 10.1038/sj.bmt.1701907. Bone Marrow Transplant. 1999. PMID: 10467326

6

High-dose therapy in breast cancer: out of favor but not out of promise.

Glück S, Stewart D. Glück S, et al. Bone Marrow Transplant. 2000 May;25(10):1017-9. doi: 10.1038/sj.bmt.1702388. Bone Marrow Transplant. 2000. PMID: 10828859

7

High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma.

Cheng T, Forsyth P, Chaudhry A, Morris D, Glück S, Russell JA, Stewart DA. Cheng T, et al. Among authors: gluck s. Bone Marrow Transplant. 2003 Apr;31(8):679-85. doi: 10.1038/sj.bmt.1703917. Bone Marrow Transplant. 2003. PMID: 12692608

8

Micrometastases in apheresis products predict shorter progression-free and overall survival in patients with breast cancer undergoing high-dose chemotherapy (HDCT) and autologous blood stem cell transplantation (ABSCT).

Syme R, Stewart D, Rodriguez-Galvez M, Luider J, Auer Y, Klassen J, Morris D, Brown C, Russell J, Glück S. Syme R, et al. Among authors: gluck s. Bone Marrow Transplant. 2003 Aug;32(3):307-11. doi: 10.1038/sj.bmt.1704133. Bone Marrow Transplant. 2003. PMID: 12858203

9

Double high-dose therapy for Hodgkin's disease with dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP) prior to high-dose melphalan and autologous stem cell transplantation.

Stewart DA, Guo D, Glück S, Morris D, Chaudhry A, deMetz C, Klassen J, Brown CB, Russell JA. Stewart DA, et al. Among authors: gluck s. Bone Marrow Transplant. 2000 Aug;26(4):383-8. doi: 10.1038/sj.bmt.1702541. Bone Marrow Transplant. 2000. PMID: 10982284

10

The CD3- 16+ 56+ NK cell count independently predicts autologous blood stem cell mobilization.

Stewart DA, Guo D, Luider J, Auer I, Klassen J, Morris D, Brown CB, Chaudhry A, Glück S, Russell JA. Stewart DA, et al. Among authors: gluck s. Bone Marrow Transplant. 2001 Jun;27(12):1237-43. doi: 10.1038/sj.bmt.1703070. Bone Marrow Transplant. 2001. PMID: 11548841

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

346 results

Search Page